InvestorsHub Logo
Followers 0
Posts 295
Boards Moderated 0
Alias Born 08/28/2017

Re: None

Thursday, 10/12/2017 8:04:54 AM

Thursday, October 12, 2017 8:04:54 AM

Post# of 19155
$CYCA Cytta selected CardioComm as its preferred provider to augment their existing M-Health/telemedicine and IoT remote patient monitoring solution due to CardioComm’s expertise in supplying ECG monitoring devices, connectivity solutions and ECG reviewing software that are cleared as Class II medical devices by the US FDA and Health Canada regulatory authorities. CardioComm’s software as a medical device (“SaaMD”) ECG solutions are capable of accepting raw ECG data from any Bluetooth enabled ECG devices to generate an accurate ECG trace rendered on a scaled grid, delivered with information that is specific to the individual the ECG was recorded from as well as those who reviewed and reported the ECG findings. https://finance.yahoo.com/news/telemedicine-technology-joint-venture-announced-113000797.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYCA News